Oliver Young

847 total citations
17 papers, 578 citations indexed

About

Oliver Young is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, Oliver Young has authored 17 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Oliver Young's work include Estrogen and related hormone effects (10 papers), Breast Cancer Treatment Studies (9 papers) and HER2/EGFR in Cancer Research (4 papers). Oliver Young is often cited by papers focused on Estrogen and related hormone effects (10 papers), Breast Cancer Treatment Studies (9 papers) and HER2/EGFR in Cancer Research (4 papers). Oliver Young collaborates with scholars based in United Kingdom, Switzerland and United States. Oliver Young's co-authors include J. Michael Dixon, Lorna Renshaw, Mitch Dowsett, William R. Miller, E. Jane Macaskill, Dean B. Evans, Juliette Murray, David Cameron, Sharon White and Elizabeth Folkerd and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Oliver Young

16 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Young United Kingdom 10 351 311 298 145 106 17 578
E. Jane Macaskill United Kingdom 12 329 0.9× 232 0.7× 244 0.8× 133 0.9× 130 1.2× 18 533
Juliette Murray United Kingdom 11 312 0.9× 275 0.9× 276 0.9× 137 0.9× 90 0.8× 27 532
Mauro Porpiglia Italy 11 456 1.3× 564 1.8× 449 1.5× 97 0.7× 124 1.2× 27 813
Catherine Harper‐Wynne United Kingdom 13 549 1.6× 381 1.2× 360 1.2× 183 1.3× 264 2.5× 45 876
Domen Ribnikar Canada 11 291 0.8× 104 0.3× 199 0.7× 97 0.7× 151 1.4× 31 470
Brenda Deyarmin United States 13 250 0.7× 134 0.4× 300 1.0× 206 1.4× 52 0.5× 32 536
P. Neven Belgium 14 531 1.5× 189 0.6× 222 0.7× 184 1.3× 192 1.8× 24 836
Christina L. Gersch United States 12 263 0.7× 150 0.5× 100 0.3× 136 0.9× 83 0.8× 30 472
Jan Smeets Netherlands 7 261 0.7× 282 0.9× 218 0.7× 47 0.3× 110 1.0× 8 421
Steve van Os United States 9 199 0.6× 220 0.7× 138 0.5× 64 0.4× 340 3.2× 15 612

Countries citing papers authored by Oliver Young

Since Specialization
Citations

This map shows the geographic impact of Oliver Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Young more than expected).

Fields of papers citing papers by Oliver Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Young. The network helps show where Oliver Young may publish in the future.

Co-authorship network of co-authors of Oliver Young

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Young. A scholar is included among the top collaborators of Oliver Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Young. Oliver Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Retzler, Chris, et al.. (2023). Anticipatory reward dysfunction in alcohol dependence: An electroencephalography monetary incentive delay task study. SHILAP Revista de lepidopterología. 8. 100116–100116. 1 indexed citations
2.
Barber, Matthew, et al.. (2020). No evidence of benefit for laminar flow in theatre for sling-assisted, implant-based breast reconstruction. The Surgeon. 19(5). e112–e116. 1 indexed citations
3.
Dixon, J. Michael, David Cameron, Laura Arthur, et al.. (2019). Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies. Advances in Therapy. 36(4). 828–841. 12 indexed citations
4.
5.
Porteous, Mary, D. Stirling, Julia Lawton, et al.. (2018). Patients’ Views of Treatment‐Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing. Journal of Genetic Counseling. 27(6). 1459–1472. 22 indexed citations
6.
Young, Oliver, et al.. (2017). Feedback approaches and knowledge intensity in new ventures. Gothenburg University Publications Electronic Archive (Gothenburg University).
7.
Dixon, J. Michael, Arran Turnbull, Lorna Renshaw, et al.. (2015). Abstract P3-06-35: Association of estrogen receptor (ER) levels and prediction of antiproliferative effect of hormone therapy (HT) in lower ER-expressing tumors. Cancer Research. 75(9_Supplement). P3–6. 1 indexed citations
8.
Dixon, J. Michael, Lorna Renshaw, Oliver Young, et al.. (2015). P097. Intra-operative assessment of excision margins in breast conserving surgery for breast cancer using ClearEdge imaging device. European Journal of Surgical Oncology. 41(6). S54–S54. 3 indexed citations
9.
Bundred, Nigel, Angela Cramer, Julie Morris, et al.. (2010). Cyclooxygenase-2 Inhibition Does Not Improve the Reduction in Ductal Carcinoma In situ Proliferation with Aromatase Inhibitor Therapy: Results of the ERISAC Randomized Placebo-Controlled Trial. Clinical Cancer Research. 16(5). 1605–1612. 33 indexed citations
10.
Dixon, J. Michael, Lorna Renshaw, C. Langridge, et al.. (2010). Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability. Breast Cancer Research and Treatment. 125(3). 741–749. 14 indexed citations
11.
Renshaw, Lorna, Linda Williams, Oliver Young, et al.. (2009). A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Research and Treatment. 119(3). 643–651. 24 indexed citations
12.
Dixon, J. Michael, Lorna Renshaw, E. Jane Macaskill, et al.. (2008). Increase in response rate by prolonged treatment with neoadjuvant letrozole. Breast Cancer Research and Treatment. 113(1). 145–151. 80 indexed citations
13.
Dixon, J. Michael, Lorna Renshaw, Oliver Young, et al.. (2008). Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer. Journal of Clinical Oncology. 26(10). 1671–1676. 125 indexed citations
14.
Dixon, J. Michael, Dana Faratian, Sharon White, et al.. (2007). DCIS and aromatase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 106(1-5). 173–179. 6 indexed citations
15.
Mackay, Alan, Ander Urruticoechea, J. Michael Dixon, et al.. (2007). Molecular response to aromatase inhibitor treatment in primary breast cancer. Breast Cancer Research. 9(3). R37–R37. 97 indexed citations
16.
Ellis, Matthew J., Yu Tao, Oliver Young, et al.. (2006). Estrogen-Independent Proliferation Is Present in Estrogen-ReceptorHER2-Positive Primary Breast Cancer After Neoadjuvant Letrozole. Journal of Clinical Oncology. 24(19). 3019–3025. 140 indexed citations
17.
Dixon, J. Michael, Lorna Renshaw, Juliette Murray, et al.. (2005). Surgical issues surrounding use of aromatase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 95(1-5). 97–103. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Jane Macaskill Breakdown of academic impact, for papers by Juliette Murray Breakdown of academic impact, for papers by Mauro Porpiglia Breakdown of academic impact, for papers by Catherine Harper‐Wynne Breakdown of academic impact, for papers by Domen Ribnikar Breakdown of academic impact, for papers by Brenda Deyarmin Breakdown of academic impact, for papers by P. Neven Breakdown of academic impact, for papers by Christina L. Gersch Breakdown of academic impact, for papers by Jan Smeets Breakdown of academic impact, for papers by Steve van Os
Rankless by CCL
2026